Published in Circ Res on September 01, 1994
The functional landscape of mouse gene expression. J Biol (2004) 5.65
Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20
A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest (2003) 3.96
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.18
Genetic causes of human heart failure. J Clin Invest (2005) 2.79
Death begets failure in the heart. J Clin Invest (2005) 2.72
A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell (2015) 2.63
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest (2003) 2.56
Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19
Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice. Circ Res (2009) 2.12
Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res (2012) 2.06
Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc Natl Acad Sci U S A (2003) 2.05
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A (2006) 2.05
Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol (2002) 1.97
Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol (1999) 1.95
Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol (2003) 1.85
Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest (1997) 1.83
Modulation of excitation-contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger. J Physiol (2004) 1.81
Gene therapy in heart failure. Circ Res (2008) 1.79
Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol (2007) 1.74
Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL. Mol Cell Biol (2001) 1.73
Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol (1997) 1.73
Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death. J Clin Invest (2008) 1.65
Beta-adrenergic receptor signaling in the heart: role of CaMKII. J Mol Cell Cardiol (2009) 1.65
Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol (2010) 1.61
Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem J (2005) 1.60
Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest (1996) 1.59
Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am J Physiol Heart Circ Physiol (2009) 1.56
Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J Mol Cell Cardiol (2007) 1.55
Targeting phospholamban by gene transfer in human heart failure. Circulation (2002) 1.55
A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys J (1999) 1.50
Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban. Proc Natl Acad Sci U S A (2003) 1.48
Up-regulation of sarcoplasmic reticulum Ca(2+) uptake leads to cardiac hypertrophy, contractile dysfunction and early mortality in mice deficient in CASQ2. Cardiovasc Res (2012) 1.47
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res (2015) 1.46
Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim Biophys Acta (2007) 1.45
Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev (2009) 1.40
Sarcoplasmic reticulum Ca2+ content, L-type Ca2+ current and the Ca2+ transient in rat myocytes during beta-adrenergic stimulation. J Physiol (1997) 1.37
Mechanisms of altered Ca²⁺ handling in heart failure. Circ Res (2013) 1.37
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest (2001) 1.37
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest (2003) 1.33
Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol (1998) 1.32
Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. J Clin Invest (2010) 1.29
Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One (2009) 1.28
Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells (2013) 1.28
Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol (2001) 1.28
Modulation of the Ca(2+)-induced Ca(2+) release cascade by beta-adrenergic stimulation in rat ventricular myocytes. J Physiol (2001) 1.26
Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Proc Natl Acad Sci U S A (2006) 1.24
Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest (1996) 1.20
Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev (2009) 1.19
The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell (2008) 1.17
Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. J Mol Cell Cardiol (2007) 1.17
Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes. J Biol Chem (2008) 1.15
Lost in transgenesis: a user's guide for genetically manipulating the mouse in cardiac research. Circ Res (2012) 1.14
Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol (2003) 1.12
Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proc Natl Acad Sci U S A (2011) 1.12
Enhanced Ca2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice. Am J Physiol Cell Physiol (2011) 1.12
Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy. Biophys J (2001) 1.11
Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown. J Clin Invest (2001) 1.05
In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J Clin Invest (2001) 1.05
Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest (1996) 1.05
PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J Mol Cell Cardiol (2008) 1.03
Tbx5-dependent pathway regulating diastolic function in congenital heart disease. Proc Natl Acad Sci U S A (2008) 1.02
Sarcolipin protein interaction with sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) is distinct from phospholamban protein, and only sarcolipin can promote uncoupling of the SERCA pump. J Biol Chem (2013) 1.02
The role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate. Pflugers Arch (2008) 0.99
Regulation of cardiac excitation and contraction by p21 activated kinase-1. Prog Biophys Mol Biol (2009) 0.99
Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis. Basic Res Cardiol (2008) 0.98
Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation. Biochem J (1996) 0.98
Co-expression of SERCA isoforms, phospholamban and sarcolipin in human skeletal muscle fibers. PLoS One (2013) 0.98
The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb Perspect Biol (2011) 0.97
Molecular basis of diastolic dysfunction. Heart Fail Clin (2008) 0.97
Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress. Basic Res Cardiol (2013) 0.97
Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc Res (2010) 0.94
The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. J Mol Cell Cardiol (2011) 0.93
TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. J Biol Chem (2010) 0.93
Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics. Proc Natl Acad Sci U S A (2004) 0.92
Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction. Circ Res (2014) 0.92
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice. Circ Res (2013) 0.92
Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein. J Mol Cell Cardiol (2011) 0.92
A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids. Hum Mutat (2008) 0.91
Phospholamban overexpression in transgenic rabbits. Transgenic Res (2007) 0.91
Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure? J Clin Invest (2010) 0.91
Regulation of excitation-contraction coupling in mouse cardiac myocytes: integrative analysis with mathematical modelling. BMC Physiol (2009) 0.91
Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses. J Clin Invest (2014) 0.89
CaMKII regulation of phospholamban and SR Ca2+ load. Heart Rhythm (2010) 0.89
Effects of increased systolic Ca²⁺ and phospholamban phosphorylation during β-adrenergic stimulation on Ca²⁺ transient kinetics in cardiac myocytes. Am J Physiol Heart Circ Physiol (2011) 0.89
The challenge of molecular medicine: complexity versus Occam's razor. J Clin Invest (2003) 0.88
Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend. J Mol Cell Cardiol (2014) 0.87
Regional dysfunction correlates with myofiber disarray in transgenic mice with ventricular expression of ras. Am J Physiol Heart Circ Physiol (2000) 0.87
Targeting cardiomyocyte Ca2+ homeostasis in heart failure. Curr Pharm Des (2015) 0.87
Catecholaminergic-induced arrhythmias in failing cardiomyocytes associated with human HRCS96A variant overexpression. Am J Physiol Heart Circ Physiol (2011) 0.87
The N Terminus of Sarcolipin Plays an Important Role in Uncoupling Sarco-endoplasmic Reticulum Ca2+-ATPase (SERCA) ATP Hydrolysis from Ca2+ Transport. J Biol Chem (2015) 0.86
Mice deleted for heart-type cytochrome c oxidase subunit 7a1 develop dilated cardiomyopathy. Mitochondrion (2011) 0.86
Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17. Biophys J (2002) 0.86
Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae. J Physiol (2002) 0.86
Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology. Front Biosci (Landmark Ed) (2009) 0.86
Alterations in adrenergic receptor signaling in heart failure. Heart Fail Rev (2000) 0.86
Effects of C-type natriuretic peptide on rat cardiac contractility. Br J Pharmacol (1999) 0.86
Rodent models of heart failure: an updated review. Heart Fail Rev (2013) 0.85
SERCA2a: a prime target for modulation of cardiac contractility during heart failure. BMB Rep (2013) 0.85
Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport. Am J Physiol Heart Circ Physiol (2008) 0.84
TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development (1997) 6.31
Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet (1995) 4.46
Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet (1998) 3.96
Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci U S A (1986) 3.11
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell (1999) 2.68
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest (1996) 2.63
Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1989) 2.59
Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res (1991) 2.34
The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J Biol Chem (1982) 2.27
Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation (2001) 2.23
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest (1999) 2.22
Fibroblast growth factor 2 control of vascular tone. Nat Med (1998) 2.21
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 2.18
Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. Circ Res (1998) 2.16
Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem (1999) 2.15
Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development (1988) 2.12
Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol Cell Biol (1993) 2.12
Balance and hearing deficits in mice with a null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2. J Biol Chem (1998) 2.10
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res (1999) 2.01
Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci (1999) 1.93
Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet (1998) 1.89
Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell (1999) 1.88
Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation. J Biol Chem (2001) 1.88
Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature (1982) 1.83
Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A (1995) 1.81
Phospholamban: a prominent regulator of myocardial contractility. Circ Res (1996) 1.78
Phenotype resembling Gitelman's syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem (1998) 1.77
Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol (1997) 1.73
Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem J (1988) 1.73
A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists. J Biol Chem (2000) 1.72
Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol (1998) 1.72
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation (2001) 1.72
Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci U S A (1997) 1.68
Targeted disruption of the murine Na+/H+ exchanger isoform 2 gene causes reduced viability of gastric parietal cells and loss of net acid secretion. J Clin Invest (1998) 1.64
In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res (1995) 1.61
Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem (1998) 1.60
Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest (1996) 1.59
Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol (2000) 1.57
Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. J Biol Chem (1991) 1.56
Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res (1999) 1.55
Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem (1999) 1.52
Purification of a positive regulatory subunit from phage SP01-modified RNA polymerase. Nature (1977) 1.52
Replication of bacteriophage phiX174 DNA in a temperature-sensitive dnaC mutant of escherichia coli C. J Virol (1974) 1.51
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest (1999) 1.49
Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ Res (1996) 1.48
Genetically engineered mice: model systems for left ventricular failure. J Card Fail (1998) 1.48
RNA polymerase from phage SP01-infected and uninfected Bacillus subtilis. J Biol Chem (1975) 1.47
Heat shock proteins in thermotolerance and other cellular processes. Cancer Res (1987) 1.44
Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol (2001) 1.40
Keratin 12-deficient mice have fragile corneal epithelia. Invest Ophthalmol Vis Sci (1996) 1.40
TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev Biol (2001) 1.39
Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res (1999) 1.39
The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38
Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem (1990) 1.38
Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. Mol Cell Biol (1993) 1.38
Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol (2000) 1.38
Transcription specificity of an RNA polymerase fraction from bacteriophage SP01-infected B. subtilis. FEBS Lett (1973) 1.37
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest (2001) 1.37
A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol (2001) 1.37
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc Natl Acad Sci U S A (1996) 1.35
Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun (1982) 1.35
Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem (1995) 1.34
Phospholamban and cardiac contractile function. J Mol Cell Cardiol (2000) 1.32
Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology (1998) 1.31
Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest (2000) 1.29
Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem (2000) 1.28
Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res (1994) 1.27
Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology (1997) 1.26
Stomachs of mice lacking the gastric H,K-ATPase alpha -subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J Biol Chem (2000) 1.26
B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int Immunol (2000) 1.26
Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am J Pathol (1995) 1.24
Incorporation of water oxygens into intracellular nucleotides and RNA. I. Predominantly non-hydrolytic RNA turnover in Bacillus subtilis. J Mol Biol (1972) 1.24
Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem (2000) 1.23
In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest (1998) 1.22
Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem (2001) 1.21
High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium. Nature (1982) 1.21
Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol (1996) 1.20
Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol (1993) 1.19
Conversion of Bacillus subtilis RNA polymerase activity in vitro by a protein induced by phage SP01. Proc Natl Acad Sci U S A (1975) 1.18